Screener

Net loss

Name: Allogene Therapeutics Net loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Allogene Therapeutics·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$59.73M	-$50.94M	-$41.4M	-$38.81M	-$42.61M
Total	-$59.73M	-$50.94M	-$41.4M	-$38.81M	-$42.61M

Business SegmentsView metric